M&A - Dominion Capital L.L.C.

Form Type: SCHEDULE 13D/A

Filing Date: 2025-04-04

Corporate Action: Merger

Type: Update

Accession Number: 000175392625000576

Filing Summary: This Schedule 13D Amendment is filed by Dominion Capital LLC and related entities regarding their stake in ReShape Lifesciences Inc. It discusses their beneficial ownership of shares and outlines various agreements associated with their investment. Dominion Capital and its subsidiaries, including Ascent Partners Fund LLC, have acquired shares through a Securities Purchase Agreement, which involves a convertible promissory note and commitment shares. The Reporting Persons may be deemed to have shared voting and dispositive power over the shares owned by Ascent. The document details a recent merger agreement involving ReShape Lifesciences that they support, as well as constraints on share trading. Ascent holds 25,283 shares, representing a 0.76% ownership of the company. The filing is categorized as an exit filing since the reporting persons own less than 5% of the securities.